Related Experiment Video
Updated: Jan 7, 2026
09:17
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
762
Optimizing deferoxamine delivery through the skin for pressure ulcers
Katharina S Berryman1, Maria Gracia Mora Pinos1, Amy Skarsfeldt1
1Department of Surgery, University of Arizona, Tucson, AZ, USA.
Expert Opinion on Drug Delivery
|December 29, 2025
Summary
Deferoxamine (DFO) shows promise for treating chronic wounds like pressure ulcers by promoting healing pathways. However, further clinical trials are essential to confirm its effectiveness and optimize dosage for human use.
Area of Science:
- Wound Healing Research
- Pharmacology
- Dermatology
Background:
- Deferoxamine (DFO), an iron-chelator, influences hypoxia-inducible factor (HIF)-1α signaling and neovascularization.
- These mechanisms are relevant to both the prevention and healing of chronic wounds, including pressure ulcers.
Purpose of the Study:
- To review and discuss the latest developments regarding the local application of DFO for pressure ulcer treatment.
- To highlight challenges in clinical trials that have hindered FDA approval for DFO in various conditions.
Main Methods:
- Literature review focusing on DFO's local application for pressure ulcers.
- Critical discussion of existing research and clinical trial limitations.
Main Results:
- Preclinical studies suggest DFO's potential in wound healing.
- Clinical trials for DFO in wound healing have not yet been conducted.
Conclusions:
- The Deferoxamine Intradermal Delivery Patch (DIDP) shows potential for transdermal drug delivery due to its penetration capabilities.
- Further research, particularly human clinical trials, is necessary to validate findings and optimize DFO treatment for pressure ulcers.
Related Concept Videos
01:15Non-Oral Extravascular Drug Absorption Routes
460
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
460
01:15Factors Affecting Drug Distribution: Organ Perfusion Rate
542
Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
Perfusion rate-limited distribution relies on the...
542
01:16Drug Delivery: Overview
700
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
700
01:26Peripheral Artery Disease IV: Nursing Management
314
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
314